Onconetix, Inc. Investment Income, Investment Expense
Onconetix, Inc. (ONCO) reported Investment Income, Investment Expense of $231.66 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-12-10.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInvestmentExpense · last filed 2024-12-10
- Onconetix, Inc. investment income, investment expense for the quarter ending 2024-09-30 was $231.66K, a 13.91% decline year-over-year.
- Onconetix, Inc. investment income, investment expense for the quarter ending 2024-06-30 was $205.15K, a 4.14% decline year-over-year.
- Onconetix, Inc. investment income, investment expense for the quarter ending 2024-03-31 was $187.99K.
- Onconetix, Inc. investment income, investment expense for the quarter ending 2023-09-30 was $269.10K.
| Period end | Investment Income, Investment Expense 3 month | Investment Income, Investment Expense 6 month | Investment Income, Investment Expense 9 month |
|---|---|---|---|
| 2024-09-30 | $231.66K 10-Q · filed 2024-12-10 | $436.80K derived: sum of 2 quarters · filed 2024-12-10 | $625.08K 10-Q · filed 2024-12-10 |
| 2024-06-30 | $205.15K 10-Q · filed 2024-08-29 | $393.43K 10-Q · filed 2024-08-29 | |
| 2024-03-31 | $187.99K 10-Q · filed 2024-05-20 | ||
| 2023-09-30 | $269.10K 10-Q · filed 2024-12-10 | $483.09K derived: sum of 2 quarters · filed 2024-12-10 | $483.09K 10-Q · filed 2024-12-10 |
| 2023-06-30 | $214.00K 10-Q · filed 2024-08-29 | $214.00K 10-Q · filed 2024-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |